INS and Hyperglycemia: As well as delaying the onset of hyperglycaemia, desHis1Pro4Glu9-glucagon, and particularly desHis1Pro4Glu9-glucagon(Lys12PAL), improved glucose handling and insulin action in addition to augmenting pancreatic insulin stores.